Veracyte, Inc. (VCYT) stock
VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3034% below fair value
$24.23+0.22 (+0.92%)
Close on Nov 17, 2026Market cap $1.95BP/E 17.3Yield –
Veracyte gross margin
Gross margin is gross profit as a percentage of revenue.
Veracyte's gross margin for the twelve months ending Jun 30, 2026 was 71.7%. For fiscal 2025 it was 70.1%, against 66.9% the year before. The highest annual figure on record is 70.1% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 70.1% | +3.2 |
| FY2024 | Dec 31, 2024 | 66.9% | +3.3 |
| FY2023 | Dec 31, 2023 | 63.6% | +4.4 |
| FY2022 | Dec 31, 2022 | 59.2% | −10.8 |
| FY2019 | Dec 31, 2019 | 70.0% | +6.0 |
| FY2018 | Dec 31, 2018 | 64.0% | +3.2 |
| FY2017 | Dec 31, 2017 | 60.8% | −0.1 |
| FY2016 | Dec 31, 2016 | 60.9% | +4.3 |
| FY2015 | Dec 31, 2015 | 56.6% | +0.1 |
| FY2014 | Dec 31, 2014 | 56.5% | +14.1 |
| FY2013 | Dec 31, 2013 | 42.4% | +7.6 |
| FY2012 | Dec 31, 2012 | 34.8% | +45.4 |
| FY2011 | Dec 31, 2011 | -10.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 72.2% | +3.2 |
| Q1 FY2026 | Mar 31, 2026 | 72.7% | +3.3 |
| Q4 FY2025 | Dec 31, 2025 | 72.5% | +6.1 |
| Q3 FY2025 | Sep 30, 2025 | 69.2% | +1.0 |
| Q2 FY2025 | Jun 30, 2025 | 69.0% | +0.9 |
| Q1 FY2025 | Mar 31, 2025 | 69.5% | +5.0 |
| Q4 FY2024 | Dec 31, 2024 | 66.4% | +0.4 |
| Q3 FY2024 | Sep 30, 2024 | 68.2% | +4.2 |
| Q2 FY2024 | Jun 30, 2024 | 68.1% | +6.3 |
| Q1 FY2024 | Mar 31, 2024 | 64.5% | −3.0 |
| Q4 FY2023 | Dec 31, 2023 | 66.0% | −4.6 |
| Q3 FY2023 | Sep 30, 2023 | 64.0% | −6.9 |
| Q2 FY2023 | Jun 30, 2023 | 61.8% | −9.4 |
| Q4 FY2019 | Dec 31, 2019 | 67.5% | +1.3 |
| Q3 FY2019 | Sep 30, 2019 | 70.6% | +5.8 |
| Q2 FY2019 | Jun 30, 2019 | 70.9% | +7.1 |
| Q1 FY2019 | Mar 31, 2019 | 71.2% | +10.4 |
| Q4 FY2018 | Dec 31, 2018 | 66.2% | +5.8 |
| Q3 FY2018 | Sep 30, 2018 | 64.8% | +5.7 |
| Q2 FY2018 | Jun 30, 2018 | 63.8% | +1.6 |
| Q1 FY2018 | Mar 31, 2018 | 60.7% | −0.9 |
| Q4 FY2017 | Dec 31, 2017 | 60.4% | −4.0 |
| Q3 FY2017 | Sep 30, 2017 | 59.1% | −6.7 |
| Q2 FY2017 | Jun 30, 2017 | 62.2% | – |
| Q1 FY2017 | Mar 31, 2017 | 61.7% | – |
| Q4 FY2016 | Dec 31, 2016 | 64.3% | – |
| Q3 FY2016 | Sep 30, 2016 | 65.8% | – |
See a number that looks wrong?